Skip to main content
. 2019 Oct 17;19:862. doi: 10.1186/s12879-019-4453-x

Table 1.

Summary of Literature Cases with ICL and Primary Pulmonary Manifestations

Reference Year Gender Age Clinical History Treatment Outcome
Ahn, et al [22]. 2005 Male 73 Non-small cell lung cancer Amphotericin B (0.5 mg/kg/day) for 15 days then switched to fluconazole 400 mg/day Continued on fluconazole until lung nodules disappeared
Lin, et al [23]. 1994 Female 33 Pure red cell aplasia and human parvovirus B19 infection Brief course of amphotericin B followed by oral fluconazole. Recurrent anemia requiring intravenous immunoglobulin for refractory anemia
McNulty, et al [24]. 1991 Male 35 N/A N/A N/A
Zaharatos, et al [25]. 2001 Male 47 Coinfection with Mycobacterium tuberculosis N/A Comment on 24 weeks total of therapy
Yuanjie, et al [26]. 2008 Female 41 N/A Lobectomy; amphotericin B 25 mg /day for 1 month; amphotericin B 25 mg/day plus 5-flucytosine 3 g /day for 6 weeks; amphotericin B 25 mg/day plus 5-flucytosine 3 g/day for 6 weeks; amphotericin B 25 mg/day plus 5-flucytosine 3 g/day for 12 weeks and fluconazole 150 mg/day as maintenance Total of four relapses, maintained on oral fluconazole.